Parkinson’s Disease Appears to Hinge on Activity of Energy-Production Enzyme
Recent findings from a preclinical study conducted by Weill Cornell Medicine researchers have uncovered a pivotal role of the enzyme PGK1 in brain cell energy production, offering new hope for Parkinson’s disease treatment. The study reveals that enhancing PGK1 activity could counteract the energy deficits in dopamine neurons, which are critically involved in Parkinson’s disease,
